August 8, 2025 | clinical trials, oncology, patient recruitment
Boosting screening & enrollment rates in a global oncology trial

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research sites across 25 countries. For this particular study, the sponsor had never run an oncology study before, so we were commissioned to provide in-country support to help sites overcome patient recruitment challenges.
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening
Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report
Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new…
Innovative Trials and Pfizer invite you to attend the live webinar
We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press…
COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.
The leading global patient recruitment organisation has opened its first international office in the Raleigh, North Carolina
Innnovative Trials’ Equality & Diversity committee raises awareness around Windrush Day and the Windrush generation
Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.
